BECKY FREDENBURG: Open Payments
NPI 1811313257 · CARO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,581 in 132 payments from 18 companies in 2025. Trend: 2023 $531 · 2024 $1,974 · 2025 $2,581
Food & beverage: $2,578Education: $3
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 23 | $408 |
| Neurocrine BioSciences, Inc. | 16 | $280 |
| Alkermes, Inc. | 13 | $276 |
| Vanda Pharmaceuticals Inc. | 14 | $252 |
| Janssen Pharmaceuticals, Inc | 10 | $230 |
| Lundbeck LLC | 10 | $225 |
| Axsome Therapeutics, Inc. | 8 | $224 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $204 |
| ABBVIE INC. | 13 | $162 |
| Supernus Pharmaceuticals, Inc. | 4 | $75 |
Products named: REXULTI, INGREZZA, ARISTADA, FANAPT, Auvelity, CAPLYTA, ABILIFY ASIMTUFII, VRAYLAR.
Industry payments across MI — which companies pay providers there.
